ESC 365 - The role of sacubitril-valsartan treatment on right ventricular function and cardiorespiratory response in patients with chronic heart failure. Single-centre experience from Myltiple patient program o

HFA Premium Access

The role of sacubitril-valsartan treatment on right ventricular function and cardiorespiratory response in patients with chronic heart failure. Single-centre experience from Myltiple patient program o

Session: Poster Session 1 - Chronic Heart Failure – Pathophysiology and Mechanisms

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor C. Chrysohoou (Athens, GR)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Christina Chrysohoou

National & Kapodistrian University of Athens, Athens (Greece)

16 presentations

1 follower

43 more presentations in this session

REMODEL: Demonstration of REverse ReMODELing Effects of sacubitril/valsartan

Skeletal muscle metabolism characteristics of HFpEF and HFrEF patients

Speaker: Doctor N. Jauert (Berlin, DE)

Morphological structure of diaphragm in patients with different class of heart failure

Speaker: Doctor K. Ilina (RU)

Clinical phenotypes and prognosis of patients with chronic heart failure with mid-range ejection fraction

Predictors of non-recovery of left ventricular systolic function in breast cancer patients with chemotherapy induced left ventricular dysfunction

Speaker: Doctor H. Yoon (Gwangju, KR)

Access the full session

Poster Session 1 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Doctor C. Chrysohoou, Doctor N. Jauert, Doctor K. Ilina, Doctor H. Yoon

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources